Although the precise mechanisms remain unclear, epidemiology studies have suggested that CAD is the result of an interaction between environmental and genetic factors. Several risk factors, such as chronic diseases (hypertension, hypercholesterolemia, diabetes mellitus, etc), smoking, age, and gender are responsible for the occurrence of CAD. In contrast, genome-wide analysis (GWAS) studies that were based on large sample sizes also deduced that genetic factors contributed to approximately 40%-50% of the risk of CAD and were also supported by family-or twin-based epidemiological studies. 5, 6 Previous studies have reported that inflammation is involved in the pathogenesis of CAD by producing oxidative damage, 7 promoting cellular proliferation, and effecting plaque evolution and destabilization 8 ; thus, the presence of proinflammatory cytokines is considered to be a risk factor for CAD.
The proinflammatory cytokine IL-17 has six isoforms (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F), 9 and IL-17A and IL-17F
have been found to play role in the formation of plaque lesions during atherogenesis. 10, 11 IL-17A and IL-17F contribute to the T cell-mediated immune response by forming a heterodimer that binds to a receptor to stimulate downstream signaling pathways. 12 In addition, genetic variations in IL-17 have been suggested to be risk factors of CAD;
however, this conclusion is not always consistent, 13 and this inconsistency may be attributed to differences in sample size, the characteristics of the enrolled participants, and ethnicities. The proinflammatory cytokine IL-23 has been implicated in atherogenesis. 14 
| MATERIAL S AND ME THODS

| Study subjects
The subjects who received their first coronary angiography were re- were enrolled in this study had to meet the inclusion criterion of having a definitive coronary artery condition that was associated with significant, single, or multiple vessel stenoses, as assessed by an angiographic examination. To lessen the potential effect of related diseases on the real results of this study, we also enrolled the patients meeting the following exclusion criteria: (a) any malignant disease; (b) liver or renal illness; (c) infection; (d) hematologic and immune disorders; (e) type I diabetes; or (f) history of rheumatic heart disease and cardiomyopathy.
All of the enrolled patients were classified into patients and controls based on their SXscores. Controls were those who had an SXscore of 0, and patients were those with CAD and an SXscore greater than 0; moreover, the patients were divided into two subgroups of low SXscore (≤22) and high SXscore (>22). 
| Coronary angiography and SXscore
A coronary angiography was performed according to the method of Judkins, and CAD was defined as the presence of a luminal diameter stenosis of ≥50% in the left main coronary artery, left anterior descending artery or its first diagonal branch, left circumflex artery or its first obtuse marginal branch, and right coronary artery. The control subjects were those who showed <30% stenosis in all major vessels. Two experienced cardiologists performed the coronary angiography on every participant and analyzed the images separately. According to baseline diagnostic angiogram, each coronary lesion that created a stenosis obstructing ≥50% of the diameter in vessels ≥1.5 mm was scored separately, and these scores were added to produce the overall SXscore, which was calculated using the SXscore algorithm. This algorithm is available on the SYNTAX website. The patients' SXscores were independently assessed by two experienced interventional cardiologists who were blinded to the carotid-US data. These cardiologists had previously calculated SXscore.
| Laboratory measurements
Blood samples of all subjects were obtained in the morning after a 10- 
| Genotyping of polymorphisms
| Statistical analysis
The ANCOVA test was used to compare the differences in biochemical parameters among groups. For the case-control study, the statistical analysis for genotype distribution was performed by the chi-square test with SPSS 13.0 for Windows (SPSS, Chicago, IL). The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a logistic regression model that was adjusted for covariates, including age, sex, BMI, smoking and alcohol consumption, history of hypertension and T2DM, and HDL-C, LDL-C, TG, and TC levels. A P value < 0.05 was considered to represent a statistically significant difference.
| RE SULTS
| General characteristics
A total of 322 patients were enrolled in this study, and 131 patients with an SXscore of 0 were identified as controls. A total of 191 patients were divided into the Low SXscore (≤22) (n = 151) and High SXscore (>22) (n = 40) subgroups. There was no significant difference among the cases and controls for BMI, age, and prevalence of hypertension and alcohol consumption (P all > 0.05). However, there was a significant difference between groups for gender (P = 0.023), prevalence of smokers (P = 0.001), and patients with T2DM (P < 0.001), as shown in Table 1 . 
Characteristics
| Clinical characteristics
For the serum indexes, no significant differences were found for the levels of BUN, Scr, sUA, or Cys (P all > 0.05) between the groups. However, the levels of FPG (CAD: 6.54 ± 2.37 vs controls: 5.84 ± 1.96, P = 0.006) and HbA1C (CAD: 6.67 ± 1.46 vs controls: 5.96 ± 1.06, P = 0.006) were higher in patients with CAD than in controls, as shown in Table 1 . For the lipid profile, the levels of HDL (1.31 ± 0.36 vs 1.15 ± 0.34, P < 0.001) and ApoA1
(1.27 ± 0.20 vs 1.20 ± 0.26, P = 0.017) were significantly higher in the controls than those in cases, as shown in 
| Association between polymorphisms and CAD risk
The genotype frequencies of the selected polymorphisms in the controls did not deviate from HWE (shown in was observed to be associated with an increased risk of CAD (CC vs TT: crude OR = 1.91, 95% CI = 1.00-3.63). However, all of these significant associations were not maintained in the adjusted model, as shown in Table 2 .
In addition, the logistic regression analysis showed that IL-17A rs8193036 and rs3748067, IL-17F rs763780, and IL23R rs1884444 and rs10889677 were not associated with CAD risk.
| Subgroup analysis of polymorphisms and CAD risk
The subgroup analysis was conducted based on the SXscore (low tients with a high SXscore, as shown in Table 3 .
| D ISCUSS I ON
It is well-known that T2DM is a risk of CAD, and the published data show that CAD affects approximately 32.2% of all people with T2DM globally, 17 which is consistent with our results showing that the prevalence of T2DM in patients was higher than that in controls and that the levels of FPG and HbA1C were higher in patients than in controls. Lp(a) has been identified as a risk factor for CAD, and elevated Lp(a) levels were suggested to be independently associated with the presence and severity of CAD in patients with T2DM. 18 In this study, we observed that the level of Lp(a) in patients was higher than that in controls. In contrast, the levels of the protective factors HDL-c and ApoA1 were higher in the controls than in the patients.
The IL-17A rs2275913 polymorphism is a substitution of the G by an A nucleotide base in the promoter region, and it has been suggested to be associated with several diseases, including CAD 19,20 ; however, this association may be inconsistent, as a published metaanalysis showed that rs2275913 was not associated with risk of CAD. 13 In this study, we observed the rs2275913 AA and AG/AA genotype to be associated with an increased risk of CAD, which was consistent with the results of previous studies. 20 In contrast, the significant association could not be maintained after the analysis was adjusted for the demographic characteristics of participants, indicating that the association between rs2275913 and CAD risk could be modified by patient characteristics. A functional study found that the rs2275913 A allele is associated with a higher promoter activity of IL-17A, suggesting that the rs2275913 AA genotype appears to contribute to greater levels of inflammation, which can lead to several diseases, including CAD; this finding was consistent with the previous results showing that IL-17 may contribute to the severity of CAD.
21
For the IL-23R polymorphisms, we observed a borderline significant association between IL-23R rs6682925 and the risk of CAD that was consistent with the results of the previous study. 22 A functional study revealed that the rs6682925 C allele may increase process which was related to the progression of CAD. 26 Moreover, the IL-23 level was suggested to be a marker of patients with CAD. 24 This study attempted to investigate the contributions of the IL-17A and IL-23R polymorphisms to CAD susceptibility. Although polymorphisms in IL-17A or IL-23R were shown by several previous studies to be associated with the risk of CAD, to our knowledge, this is the first study that attempted to investigate the polymorphisms in the genes that are involved in the IL-23/IL-17 axis in an attempt to illustrate the systemic genetic risk of CAD. To confirm the lack of CAD in the individuals of the control group, we enrolled patients who had an SXscore of 0 as controls, which was in accordance with the purpose of this study. In addition, we reported all of the results of this study, which may be discussed in further studies. However, there were some limitations, which will be described. First, the sample size of this study was relatively small, and this may limit the statistical power, especially for the subgroup analysis. Second, CAD is a chronic disease; several environmental factors are involved in the pathology of disease progression, so the results of this study may be affected by limited characteristics of the enrolled subjects. Third, we failed to investigate the association between genotypes and gene expression.
In short, this study suggested that T2DM, Lp(a), HDL-c, and ApoA1
were risk factors of CAD, and the IL-17A rs2275913 and IL-23R rs6682925 polymorphisms may contribute to the susceptibility of CAD, which should be confirmed by further studies with large sample sizes.
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